Status:
COMPLETED
Post Operative Pain Control Using Ropivacaine and the ON-Q System in the Adult Pectus Excavatum Patient
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
Halyard Health
Conditions:
Pectus Excavatum
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Pectus excavatum (PE) is a common chest wall deformity where the sternum is displaced posteriorly. In severe cases, surgery is performed to correct the defect. In recent years, minimally invasive surg...
Detailed Description
Subjects meeting eligibility criteria were randomized to one of two arms for postoperative pain control: the On-Q system versus epidural. All subjects had additional pain management as per standardize...
Eligibility Criteria
Inclusion
- Patients who are scheduled for repair of their pectus excavatum with minimally invasive (MIRPE) placement of steel or titanium braces at Mayo Clinic Arizona
- Must be able to take oral medications preoperatively and postoperatively.
Exclusion
- American Society of Anesthesiology class IV or higher
- Allergic to Ropivacaine or other local anesthetics
- NSAID allergy
- Specific epidural contraindication
- Currently using opioids, sedatives, or hypnotics
- Are pregnant as verified by preoperative pregnancy testing
- Inability to place an epidural, patient refusal for epidural, or failure of an epidural to be properly placed or maintain proper placement for adequate pain control.
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT01816477
Start Date
April 1 2013
End Date
May 1 2015
Last Update
April 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Arizona
Phoenix, Arizona, United States, 85054